Início > BIGG > Resultado da busca

    Resultados: 22

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk for Serogroup B Meningococcal Disease

    MMWR recomm. rep; 64 (22), 2015
    In October 2014, the Food and Drug Administration (FDA) licensed the first serogroup B meningococcal (MenB) vaccine (MenB-FHbp [Trumenba®, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc., Philadelphia, Pennsylvania]) as a 3-dose series. The FDA licensed a second MenB vaccine (MenB-4C [Bexsero®...
    Vacinas Meningocócicas/uso terapêutico, Infecções Meningocócicas/imunologia, Programas de Imunização
    Texto completo

    ACIP evidence to recommendations for use of moderna COVID-19 vaccine in children ages 6 months – 5 years and Pfizer-BioNTech COVID-19 vaccine in children ages 6 months – 4 years under an Emergency use authorization

    United States. United States federal agency. Department of Health and Human Services. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices.
    he emergence of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), has led to a global pandemic with substantial societal and economic impacts on individual persons and communities. In the United States, more than 85 million cases and more than 1,000,000 COVID-19-associated deaths hav...
    Vacina BNT162/efeitos adversos, Vacina BNT162/administração & dosagem, Programas de Imunização/normas, Vacina de mRNA-1273 contra 2019-nCoV/efeitos adversos, Vacina de mRNA-1273 contra 2019-nCoV/administração & dosagem, COVID-19/prevenção & controle
    Texto completo